No profile data available.
Ceribell, Inc. (CBLL) is a healthcare company in the targeted healthcare equipment industry, based in Sunnyvale, United States, with about 327 full-time employees.
It reported revenue of $89.06 million for fiscal year 2025, up 36.1% from fiscal year 2024, and net income of -$53.41 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $28.10 million, up 32.5% from a year before. Its market capitalization was $906.87 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting.
Ceribell reported $89.06 million in revenue for fiscal year 2025, up 36.1% from $65.44 million in fiscal year 2024. In Q2 2026 revenue was $28.10 million.
$906.87 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Staar Surgical Company (STAA), Procept BioRobotics Corporation (PRCT), Integra LifeSciences Holdings Corporation (IART), Tactile Systems Technology, Inc. (TCMD).